Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane

Cancer Letters

Volumn 121, Issue 2, 1997, Pages 211-216

  Sekine, Kazunori ^a   Ushida, Yoshihiko ^a   Kuhara, Tetsuya ^a   Iigo, Masaaki ^a   Baba Toriyama, Hiroyasu ^a   Moore, Malcolm A ^a   Murakoshi, Michiaki ^b   Satomi, Yoshiko ^b   Nishino, Hoyoku ^b   Kakizoe, Tadao ^c   Tsuda, Hiroyuki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Aberrant crypt foci; Bovine lactoferrin; Natural killer activity

Indexed keywords

AZOXYMETHANE; CARCINOGEN; LACTOFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DIET SUPPLEMENTATION; LACTOBACILLUS BIFIDUS; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; BIFIDOBACTERIUM; CARCINOGENS; CHEMOPREVENTION; COLONIC NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; KILLER CELLS, NATURAL; LACTOFERRIN; MALE; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344;

ANIMALIA; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BOVINAE; LACTOBACILLUS;

EID: 0031469568     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00358-3     Document Type: Article

References (25)

1. Lonnerdal B., Iyer S. Lactoferrin: molecular structure and biological function. Annu. Rev. Nutr. 15:1995;93-110.
2. Sekine K., Watanabe E., Nakamura J., Takasuka N., Kim D.J., Asamoto M., Vladimir K., Baba-Toriyama H., Tomonori O., Moore M.A., Masuda M., Sugimoto H., Nishino H., Kakizoe T., Tsuda H. Inhibition of azoxymethane initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn. J. Cancer Res. 88:1997;523-526.
3. Bezault J., Bhimani R., Wiprovnick J., Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res. 54:1994;2310-2312.
4. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93:1995;55-71.
5. Pretlow T.P., O'Riordan M.A., Somich G.A., Amini S.B., Pretlow T.G. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis. 13:1992;1509-1512.
6. Singh J., Rivereson A., Tomita M., Shimamura S., Ishibashi N., Reddy B.S. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis. 18:1997;833-841.
7. Kulkarni N., Reddy B.S. Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial beta-glucuronidase. Proc. Soc. Exp. Biol. Med. 207:1994;278-283.
8. Challa A., Rao D.R., Chawan C.B., Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 18:1997;517-521.
9. Shau H., Kim A., Golub S.H. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukocyte Biol. 51:1992;343-349.
10. Baten A., Ullah A., Tomazic V.J., Shamsuddin A.M. Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis. 10:1989;1595-1598.
11. Law B.A., Reiter B. The isolation and bacteriostatic properties of latoferrin from bovine milk whey. J. Dairy Res. 44:1977;595-599.
12. Sekine K., Kawashima T., Hashimoto Y. Comparison of the TNF-a levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobacteria Microflora. 13:1994;79-89.
13. Winter B.K., Wu S., Nelson A.C., Pollack S.B. Renal cell carcinoma and natural killer cells: studies in a novel rat model in vitro and in vivo. Cancer Res. 52:1992;6279-6286.
14. Pence B.C. Role of calcium in colon cancer prevention: experimental and clinical studies. Mutat. Res. 290:1993;87-95.
15. Tsuru S., Shinomiya N., Taniguchi M., Shimazaki H., Tanigawa K., Nomoto K. Inhibition of tumor growth by dairy products. J. Clin. Lab. Immunol. 25:1988;177-183.
16. Abdelali H., Cassand P., Soussotte V., Daubeze M., Bouley C., Narbonne J.F. Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr. Cancer. 24:1995;121-132.
17. Bounous G., Papenburg R., Kongshavn P.A., Gold P., Fleiszer D. Dietary whey protein inhibits the development of dimethylhydrazine induced malignancy. Clin. Invest. Med. 11:1988;213-217.
18. Papenburg R., Bounous G., Fleiszer D., Gold P. Dietary milk proteins inhibit the development of dimethylhydrazine-induced malignancy. Tumour Biol. 11:1990;129-136.
19. McIntosh G.H., Regester G.O., Le L.R., Royle P.J., Smithers G.W. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J. Nutr. 125:1995;809-816.
20. Kennedy R.S., Konok G.P., Bounous G., Baruchel S., Lee T.D. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study. Anticancer Res. 15:1995;2643-2649.
21. Saito H., Takase M., Tamura Y., Shimamura S., Tomita M. Physicochemical and antibacterial properties of lactoferrin and its hydrolysate produced by heat treatment at acidic pH. Adv. Exp. Med. Biol. 357:1994;219-226.
22. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol. Today. 16:1995;417-419.
23. Sekine K., Ohta J., Onishi M., Tatsuki T., Shimokawa Y., Toida T., Kawashima T., Hashimoto Y. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol. Pharm. Bull. 18:1995;148-153.
24. Wei W.Z., Fulton A., Winkelhake J., Heppner G. Correlation of natural killer activity with tumorigenesis of a preneoplastic mouse mammary lesion. Cancer Res. 49:1989;2709-2715.
25. Dove W.F., Clipson L., Gould K.A., Luongo C., Marshall D.J., Moser A.R., Newton M.A., Jacoby R.F. Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res. 57:1997;812-814.